Student’s bad eating habits could herald lifelong illness
Recent research emerging from UBC Okanagan delivers a stern warning: the unhealthy eating habits fostered during one’s university tenure could set the stage for a lifetime mired in significant health challenges, including obesity, respiratory ailments, and depression. The caution comes from Dr. Joan Bottorff, a distinguished Professor affiliated with UBCO’s School of Nursing, who is part...Read More
Unprecedented surge in applications for obesity medicine certification among U.S. physicians
The realm of obesity medicine is witnessing a remarkable influx of interest among U.S. physicians, showcased by a record-setting number of nearly 1,900 applicants aspiring to gain certification in this burgeoning field, as per recent figures released by the American Board of Obesity Medicine (ABOM). The forthcoming certification examination slated for October has garnered the participation of...Read More
Prolonged consumption of artificial sweeteners could elevate obesity risks, study finds
A recent study has established a concerning connection between long-term intake of artificial sweeteners such as aspartame and saccharin, as well as diet sodas, and an augmented risk of obesity. The findings were featured in the International Journal of Obesity, following an extensive examination of the relationships between the consumption of these substances and a variety of health...Read More
New research links early adolescent weight gain to higher depression risks in teen years
Recent studies indicate a strong correlation between elevated body mass index (BMI) in children and increased instances of depression during their teenage years. This correlation, as pinpointed in the comprehensive research conducted by King’s College London, has flagged early adolescence as a critical period wherein weight gain can significantly influence the onset of depressive symptoms...Read More
Weight-loss medication Wegovy to be prescribed by NHS amid limited availability
In the UK, the NHS (National Health Service) in England is gearing up to administer the weight-loss drug Wegovy, also known by its scientific name semaglutide, under a “controlled and limited launch.” This initiative, starting from September 4, 2023, will operate via specialist NHS weight management services, where the drug will be prescribed in conjunction with a regimen involving a...Read More
Obesity-linked heart deaths triple in 20 years
Recent research disclosed a concerning surge in the number of US adults succumbing to heart disease where obesity was cited as a pivotal contributing factor, exhibiting a threefold rise between 1999 and 2020. This alarming revelation was documented in a study published in the Journal of the American Heart Association, leveraging data encapsulated in the comprehensive database curated by the...Read More